Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | +3.12% | -16.75% | -0.28% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | 0.07 | Capitalization | 9.71M |
---|---|---|---|---|---|
Net income 2022 | -24M | Net income 2023 | -21M | EV / Sales 2022 | - |
Net cash position 2022 | 10.26M | Net Debt 2023 | 34.27M | EV / Sales 2023 | 646,758,000 x |
P/E ratio 2022 |
-0.4
x | P/E ratio 2023 |
-0.44
x | Employees | 8 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.69% |
1 day | +3.12% | ||
1 week | -16.75% | ||
Current month | -25.42% | ||
1 month | -20.80% | ||
3 months | +7.18% | ||
6 months | +22.60% | ||
Current year | -0.28% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjeev Luther
CEO | Chief Executive Officer | 62 | Dec. 31 |
Sandra Gurrola
DFI | Director of Finance/CFO | 57 | 21-06-20 |
Megan Yung
LAW | General Counsel | - | 23-05-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Bristol
CHM | Chairman | 77 | 23-10-29 |
William Wexler
BRD | Director/Board Member | 65 | 22-06-06 |
Dorothy Clarke
BRD | Director/Board Member | 59 | 23-08-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.79 | +3.12% | 15,061 |
24-04-25 | 1.736 | -0.25% | 5,432 |
24-04-24 | 1.74 | -11.22% | 12,664 |
24-04-23 | 1.96 | -8.41% | 9,867 |
24-04-22 | 2.14 | -0.47% | 5,610 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-0.28% | 9.39M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- ERNA Stock